Nicotine vaccine - Tria Bioscience
Latest Information Update: 14 Jul 2016
At a glance
- Originator TRIA Bioscience
- Class Drug withdrawal therapies; Smoking cessation therapies; Vaccines
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Smoking withdrawal
Most Recent Events
- 14 Jul 2016 Preclinical trials in Smoking withdrawal in USA (unspecified route)